Allison Dunn

Allison Dunn, PharmD, MS, is a Research Assistant Professor in the Department of Practice, Science, and Health Outcomes Research at the University of Maryland School of Pharmacy

Headshot of Allison Dunn

Allison Dunn, PhD, MS
Research Assistant Professor
Department of Practice, Science, and Health Outcomes Research
University of Maryland School of Pharmacy
20 N Pine Street, N523
Baltimore, MD 21201
E-mail: adunn@rx.umaryland.edu
LinkedIn

Postdoctoral – Not accepting applicants

Education

PharmD, University of Maryland School of Pharmacy

MS, Pharmacometrics, University of Maryland School of Pharmacy

BS, Bioengineering, University of Maryland, College Park

Research Interests

Precision medicine, pharmacometrics, and the utilization of real-world data for treatment optimization

Current Projects

  • Evaluation of the indotecan-neutropenia relationship in patients with solid tumors using population pharmacokinetic modeling and Bayesian regressions
  • Quantifying the effect of hepatic impairment on the pharmacokinetic disposition of belinostat and its five metabolites using population pharmacokinetic modeling

Selected Publications

  1. Dunn A, Ditmarsch M, Kastelein JJP, et al. Guiding Dyslipidemia Treatment: A Population Pharmacokinetic-Pharmacodynamic Framework for Obicetrapib. J Clin Pharmacol. Published online May 8, 2024. doi:10.1002/jcph.2448
  2. Dunn A, Takebe N, Chen A, et al. The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancers. Cancer Chemother Pharmacol. Published online March 14, 2024. doi:10.1007/s00280-024-04651-x
  3. Gordon O, Gobburu JVS, Dunn A. Molecular Imaging to Study Antimicrobial Pharmacokinetics In Vivo. J Infect Dis. 2023;228(Suppl 4):S297-S301. doi:10.1093/infdis/jiad011
  4. Dunn A, Gobburu JVS. The trajectory of pharmacometrics to support drug licensing and labelling. Br J Clin Pharmacol. Published online April 2, 2023. doi:10.1111/bcp.15728
  5. Beumer JH, Kennard BC, Holleran JL, …, Dunn A. Evaluating the indotecan-neutropenia relationship in patients with solid tumors by population pharmacokinetic modeling and sigmoidal Emax regressions. Cancer Chemother Pharmacol. 2023;91(3):219-230. doi:10.1007/s00280-023-04509-8
  6. Dunn, A., Jung, D., Bollinger, L. L., Krams, M., Smith, B. P., & Gobburu, J. V. (2022). Accelerating the availability of medications to pediatric patients by optimizing the use of extrapolation of efficacy. Therapeutic Innovation & Regulatory Science. doi:10.1007/s43441-022-00411-2
  7. Dunn, A., Moffett, B. S., Ivaturi, V., & Gobburu, J. V. (2021). Characterization of drug–drug interactions on the pharmacokinetic disposition of Busulfan in paediatric patients during haematopoietic stem cell transplantation conditioning. British Journal of Clinical Pharmacology, 88(5), 2223-2235. doi:10.1111/bcp.15151